DEF 14A

Company

Calidi Biotherapeutics, Inc.

Filed

May 23, 2025

Period of Report

May 23, 2025

Accession Number

0001641172-25-012252

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →